Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
145.92B
Market cap145.92B
Price-Earnings ratio
14.95
Price-Earnings ratio14.95
Dividend yield
6.71%
Dividend yield6.71%
Average volume
49.85M
Average volume49.85M
High today
$25.94
High today$25.94
Low today
$25.55
Low today$25.55
Open price
$25.89
Open price$25.89
Volume
59.47M
Volume59.47M
52 Week high
$27.69
52 Week high$27.69
52 Week low
$20.92
52 Week low$20.92

Stock Snapshot

With a market cap of 145.92B, Pfizer(PFE) trades at $25.77. The stock has a price-to-earnings ratio of 14.95 and currently yields dividends of 6.7%.

On 2026-01-19, Pfizer(PFE) stock moved within a range of $25.55 to $25.94. With shares now at $25.77, the stock is trading +0.9% above its intraday low and -0.7% below the session's peak.

Trading volume for Pfizer(PFE) stock has reached 59.47M, versus its average volume of 49.85M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

PFE News

The Motley Fool 2h
Down 55%, Should You Buy the Dip on Pfizer?

Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard? Pfizer (PFE 0.93%) is in the Wall Street doghouse. I...

Down 55%, Should You Buy the Dip on Pfizer?
Nasdaq 9h
What to Expect From Pfizer's Non-Oncology Business in Q4?

Pfizer PFE is set to release its fourth-quarter and full-year 2025 results on Feb. 3, with investor attention focused on oncology sales, which generate more tha...

What to Expect From Pfizer's Non-Oncology Business in Q4?
Nasdaq 2d
Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,700 in Passive Income in 2026

Key Points These five stocks offer dividend yields of up to 9.4%. They represent different sectors, including communication services, energy, financials, heal...

Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,700 in Passive Income in 2026

Analyst ratings

57%

of 28 ratings
Buy
39.3%
Hold
57.1%
Sell
3.6%

More PFE News

The Motley Fool 2d
The Best Dividend Stocks to Buy in 2026 and Hold Forever -- Including Pfizer and United Parcel Service

All three of these stocks sport dividend yields above 6%. If you're in the market for some no-brainer dividend stocks, I have some good and less-good news for...

The Best Dividend Stocks to Buy in 2026 and Hold Forever -- Including Pfizer and United Parcel Service
TipRanks 3d
Notable open interest changes for January 16th

Thursday’s total option volume of 76.7 million contracts resulted in net open interest growth of 7.52 million calls and 5.23 million puts. Pfizer (PFE), NVIDIA...

Simply Wall St 4d
Has The Market Overlooked Pfizer After The Post‑Pandemic Reset?

If you are wondering whether Pfizer's current share price fairly reflects its fundamentals, you are not alone. This article is designed to help you weigh that u...

Has The Market Overlooked Pfizer After The Post‑Pandemic Reset?
TipRanks 4d
Pfizer Advances Prazosin Manufacturing Shift With New Bioequivalence Study

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools f...

TipRanks 4d
Pfizer’s TOFAst Real-World Study in Ulcerative Colitis: What Investors Should Watch

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools f...

Sherwood News 5d
Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025. Revolution Medici...

Big Pharma enters 2026 with an appetite for deals
TipRanks 5d
Pfizer Advances CGRP Migraine Asset With New Bioequivalence Study

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Pfizer Tests New Migraine Drug Formulation in Early-Stage...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .